<!DOCTYPE HTML>
<html lang="en" class="sidebar-visible no-js rust">
    <head>
        <!-- Book generated using mdBook -->
        <meta charset="UTF-8">
        <title>Anti-Neoplastics - Medical Summary</title>
        
        


        <!-- Custom HTML head -->
        


        <meta content="text/html; charset=utf-8" http-equiv="Content-Type">
        <meta name="description" content="">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        <meta name="theme-color" content="#ffffff" />

        
        <link rel="icon" href="../favicon.svg">
        
        
        <link rel="shortcut icon" href="../favicon.png">
        
        <link rel="stylesheet" href="../css/variables.css">
        <link rel="stylesheet" href="../css/general.css">
        <link rel="stylesheet" href="../css/chrome.css">
        
        <link rel="stylesheet" href="../css/print.css" media="print">
        

        <!-- Fonts -->
        <link rel="stylesheet" href="../FontAwesome/css/font-awesome.css">
        
        <link rel="stylesheet" href="../fonts/fonts.css">
        

        <!-- Highlight.js Stylesheets -->
        <link rel="stylesheet" href="../highlight.css">
        <link rel="stylesheet" href="../tomorrow-night.css">
        <link rel="stylesheet" href="../ayu-highlight.css">

        <!-- Custom theme stylesheets -->
        
        <link rel="stylesheet" href="../src/custom.css">
        

        
    </head>
    <body>
        <!-- Provide site root to javascript -->
        <script type="text/javascript">
            var path_to_root = "../";
            var default_theme = window.matchMedia("(prefers-color-scheme: dark)").matches ? "navy" : "rust";
        </script>

        <!-- Work around some values being stored in localStorage wrapped in quotes -->
        <script type="text/javascript">
            try {
                var theme = localStorage.getItem('mdbook-theme');
                var sidebar = localStorage.getItem('mdbook-sidebar');

                if (theme.startsWith('"') && theme.endsWith('"')) {
                    localStorage.setItem('mdbook-theme', theme.slice(1, theme.length - 1));
                }

                if (sidebar.startsWith('"') && sidebar.endsWith('"')) {
                    localStorage.setItem('mdbook-sidebar', sidebar.slice(1, sidebar.length - 1));
                }
            } catch (e) { }
        </script>

        <!-- Set the theme before any content is loaded, prevents flash -->
        <script type="text/javascript">
            var theme;
            try { theme = localStorage.getItem('mdbook-theme'); } catch(e) { }
            if (theme === null || theme === undefined) { theme = default_theme; }
            var html = document.querySelector('html');
            html.classList.remove('no-js')
            html.classList.remove('rust')
            html.classList.add(theme);
            html.classList.add('js');
        </script>

        <!-- Hide / unhide sidebar before it is displayed -->
        <script type="text/javascript">
            var html = document.querySelector('html');
            var sidebar = 'hidden';
            if (document.body.clientWidth >= 1080) {
                try { sidebar = localStorage.getItem('mdbook-sidebar'); } catch(e) { }
                sidebar = sidebar || 'visible';
            }
            html.classList.remove('sidebar-visible');
            html.classList.add("sidebar-" + sidebar);
        </script>

        <nav id="sidebar" class="sidebar" aria-label="Table of contents">
            <div class="sidebar-scrollbox">
                <ol class="chapter"><li class="chapter-item "><a href="../genetics/index.html"><strong aria-hidden="true">1.</strong> Genetics</a><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><a href="../genetics/01.html"><strong aria-hidden="true">1.1.</strong> Genetics Terms</a></li><li class="chapter-item "><a href="../genetics/02.html"><strong aria-hidden="true">1.2.</strong> X-Linked Recessive Diseases</a></li><li class="chapter-item "><a href="../genetics/03.html"><strong aria-hidden="true">1.3.</strong> Autosomal Dominant Diseases</a></li><li class="chapter-item "><a href="../genetics/04.html"><strong aria-hidden="true">1.4.</strong> Autosomal Recessive Disease</a></li><li class="chapter-item "><a href="../genetics/05.html"><strong aria-hidden="true">1.5.</strong> Trisomy (21, 18, and 13) &amp; Nondisjunction Genetics</a></li><li class="chapter-item "><a href="../genetics/06.html"><strong aria-hidden="true">1.6.</strong> Prader-Willi vs. Angelman Syndrome</a></li><li class="chapter-item "><a href="../genetics/07.html"><strong aria-hidden="true">1.7.</strong> Hardy-Weinberg Equations &amp; Genetics</a></li><li class="chapter-item "><a href="../genetics/08.html"><strong aria-hidden="true">1.8.</strong> X-linked Pedigrees</a></li><li class="chapter-item "><a href="../genetics/09.html"><strong aria-hidden="true">1.9.</strong> Trinucleotide Repeats</a></li></ol></li><li class="chapter-item "><a href="../biochemistry/index.html"><strong aria-hidden="true">2.</strong> Biochemistry &amp; Molecular Science</a><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><a href="../biochemistry/01.html"><strong aria-hidden="true">2.1.</strong> Notifiable Diseases</a></li><li class="chapter-item "><a href="../biochemistry/02.html"><strong aria-hidden="true">2.2.</strong> P450 Enzyme System (Inducers, Inhibitors, &amp; Subtypes)</a></li><li class="chapter-item "><a href="../biochemistry/03.html"><strong aria-hidden="true">2.3.</strong> Vitamins</a></li><li class="chapter-item "><a href="../biochemistry/04.html"><strong aria-hidden="true">2.4.</strong> Glycolysis</a></li><li class="chapter-item "><a href="../biochemistry/05.html"><strong aria-hidden="true">2.5.</strong> Pyruvate Pathways &amp; Metabolism</a></li><li class="chapter-item "><a href="../biochemistry/06.html"><strong aria-hidden="true">2.6.</strong> TCA/Citric Acid (Krebs) Cycle</a></li><li class="chapter-item "><a href="../biochemistry/07.html"><strong aria-hidden="true">2.7.</strong> Electron Transport Chain (Oxidative Phosphorylation)</a></li><li class="chapter-item "><a href="../biochemistry/08.html"><strong aria-hidden="true">2.8.</strong> HMP Shunt (Pentose Pathway)</a></li><li class="chapter-item "><a href="../biochemistry/09.html"><strong aria-hidden="true">2.9.</strong> Catecholamine Synthesis</a></li><li class="chapter-item "><a href="../biochemistry/10.html"><strong aria-hidden="true">2.10.</strong> Amino Acids</a></li><li class="chapter-item "><a href="../biochemistry/11.html"><strong aria-hidden="true">2.11.</strong> Urea Cycle</a></li><li class="chapter-item "><a href="../biochemistry/12.html"><strong aria-hidden="true">2.12.</strong> Fatty Acid Synthesis</a></li><li class="chapter-item "><a href="../biochemistry/13.html"><strong aria-hidden="true">2.13.</strong> Fatty Acid (Beta) Oxidation</a></li><li class="chapter-item "><a href="../biochemistry/14.html"><strong aria-hidden="true">2.14.</strong> Ketone Body Synthesis</a></li><li class="chapter-item "><a href="../biochemistry/15.html"><strong aria-hidden="true">2.15.</strong> Glutathione Pathways</a></li><li class="chapter-item "><a href="../biochemistry/16.html"><strong aria-hidden="true">2.16.</strong> Metabolic Fuel &amp; Starvation</a></li><li class="chapter-item "><a href="../biochemistry/17.html"><strong aria-hidden="true">2.17.</strong> Lipid Transport</a></li><li class="chapter-item "><a href="../biochemistry/18.html"><strong aria-hidden="true">2.18.</strong> Familial Dyslipidemia’s</a></li><li class="chapter-item "><a href="../biochemistry/19.html"><strong aria-hidden="true">2.19.</strong> Glycogen Storage Diseases</a></li><li class="chapter-item "><a href="../biochemistry/20.html"><strong aria-hidden="true">2.20.</strong> Fructose Metabolism</a></li><li class="chapter-item "><a href="../biochemistry/21.html"><strong aria-hidden="true">2.21.</strong> Galactose Metabolism</a></li><li class="chapter-item "><a href="../biochemistry/22.html"><strong aria-hidden="true">2.22.</strong> Lysosomal Storage Diseases</a></li><li class="chapter-item "><a href="../biochemistry/23.html"><strong aria-hidden="true">2.23.</strong> Alcohol Metabolism</a></li><li class="chapter-item "><a href="../biochemistry/24.html"><strong aria-hidden="true">2.24.</strong> Types of Collagen</a></li></ol></li><li class="chapter-item expanded "><a href="../pharmacology/index.html"><strong aria-hidden="true">3.</strong> Pharmacology</a><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><a href="../pharmacology/01.html"><strong aria-hidden="true">3.1.</strong> High Yield USMLE</a></li><li class="chapter-item "><a href="../pharmacology/02.html"><strong aria-hidden="true">3.2.</strong> Pharmacodynamics and Weak Acids and Bases</a></li><li class="chapter-item "><a href="../pharmacology/03.html"><strong aria-hidden="true">3.3.</strong> ADME and Pharmacokinetics</a></li><li class="chapter-item "><a href="../pharmacology/04.html"><strong aria-hidden="true">3.4.</strong> Antibiotics, Cell Wall Inhibitors</a></li><li class="chapter-item "><a href="../pharmacology/05.html"><strong aria-hidden="true">3.5.</strong> Antibiotics, Protein Synthesis Inhibitors</a></li><li class="chapter-item "><a href="../pharmacology/06.html"><strong aria-hidden="true">3.6.</strong> Antibiotics, MISC</a></li><li class="chapter-item "><a href="../pharmacology/07.html"><strong aria-hidden="true">3.7.</strong> Anti-Fungal Agents</a></li><li class="chapter-item "><a href="../pharmacology/08.html"><strong aria-hidden="true">3.8.</strong> Anti-Tuberculosis Drugs</a></li><li class="chapter-item "><a href="../pharmacology/09.html"><strong aria-hidden="true">3.9.</strong> Malaria</a></li><li class="chapter-item "><a href="../pharmacology/10.html"><strong aria-hidden="true">3.10.</strong> Misc Parasites</a></li><li class="chapter-item "><a href="../pharmacology/11.html"><strong aria-hidden="true">3.11.</strong> Anti-virals &amp; HIV</a></li><li class="chapter-item "><a href="../pharmacology/12.html"><strong aria-hidden="true">3.12.</strong> Immunosuppressants</a></li><li class="chapter-item expanded "><a href="../pharmacology/13.html" class="active"><strong aria-hidden="true">3.13.</strong> Anti-Neoplastics</a></li><li class="chapter-item "><a href="../pharmacology/14.html"><strong aria-hidden="true">3.14.</strong> Anticoagulants &amp; Antiplatelets</a></li><li class="chapter-item "><a href="../pharmacology/15.html"><strong aria-hidden="true">3.15.</strong> Hematinics</a></li><li class="chapter-item "><a href="../pharmacology/16.html"><strong aria-hidden="true">3.16.</strong> Anti-Hyperlipidemia Agents</a></li><li class="chapter-item "><a href="../pharmacology/17.html"><strong aria-hidden="true">3.17.</strong> Diuretics</a></li><li class="chapter-item "><a href="../pharmacology/18.html"><strong aria-hidden="true">3.18.</strong> Anti-Hypertensives</a></li><li class="chapter-item "><a href="../pharmacology/19.html"><strong aria-hidden="true">3.19.</strong> Anti-Arrhythmics</a></li><li class="chapter-item "><a href="../pharmacology/20.html"><strong aria-hidden="true">3.20.</strong> Inotropes, Heart Failure, and Anti-Angina</a></li><li class="chapter-item "><a href="../pharmacology/21.html"><strong aria-hidden="true">3.21.</strong> Toxicology</a></li><li class="chapter-item "><a href="../pharmacology/22.html"><strong aria-hidden="true">3.22.</strong> Alternative Medicine</a></li><li class="chapter-item "><a href="../pharmacology/23.html"><strong aria-hidden="true">3.23.</strong> Rheumatoid Arthritis Pharmacology</a></li><li class="chapter-item "><a href="../pharmacology/24.html"><strong aria-hidden="true">3.24.</strong> Gout Pharmacology</a></li><li class="chapter-item "><a href="../pharmacology/25.html"><strong aria-hidden="true">3.25.</strong> Muscle Relaxants</a></li><li class="chapter-item "><a href="../pharmacology/26.html"><strong aria-hidden="true">3.26.</strong> Dermatology</a></li><li class="chapter-item "><a href="../pharmacology/27.html"><strong aria-hidden="true">3.27.</strong> NSAIDS and Prostaglandins</a></li><li class="chapter-item "><a href="../pharmacology/28.html"><strong aria-hidden="true">3.28.</strong> Cholinergic Nervous System</a></li><li class="chapter-item "><a href="../pharmacology/29.html"><strong aria-hidden="true">3.29.</strong> Adrenergic Nervous System</a></li><li class="chapter-item "><a href="../pharmacology/30.html"><strong aria-hidden="true">3.30.</strong> Reproductive Pharmacology</a></li><li class="chapter-item "><a href="../pharmacology/31.html"><strong aria-hidden="true">3.31.</strong> Pharmacology Asthma &amp; COPD</a></li><li class="chapter-item "><a href="../pharmacology/32.html"><strong aria-hidden="true">3.32.</strong> Anti-Histamines</a></li><li class="chapter-item "><a href="../pharmacology/33.html"><strong aria-hidden="true">3.33.</strong> Calcium Homeostasis</a></li><li class="chapter-item "><a href="../pharmacology/34.html"><strong aria-hidden="true">3.34.</strong> Hypothalamic and Pituitary Agents</a></li><li class="chapter-item "><a href="../pharmacology/35.html"><strong aria-hidden="true">3.35.</strong> Adrenocorticosteroids</a></li><li class="chapter-item "><a href="../pharmacology/36.html"><strong aria-hidden="true">3.36.</strong> Thyroid Acting Agents</a></li><li class="chapter-item "><a href="../pharmacology/37.html"><strong aria-hidden="true">3.37.</strong> Diabetes</a></li><li class="chapter-item "><a href="../pharmacology/38.html"><strong aria-hidden="true">3.38.</strong> Nausea &amp; Vomiting</a></li><li class="chapter-item "><a href="../pharmacology/39.html"><strong aria-hidden="true">3.39.</strong> Inflammatory Bowel Disease</a></li><li class="chapter-item "><a href="../pharmacology/40.html"><strong aria-hidden="true">3.40.</strong> Constipation &amp; Diarrhea</a></li><li class="chapter-item "><a href="../pharmacology/41.html"><strong aria-hidden="true">3.41.</strong> GERD Pharmacology</a></li><li class="chapter-item "><a href="../pharmacology/42.html"><strong aria-hidden="true">3.42.</strong> Parkinson's Disease</a></li><li class="chapter-item "><a href="../pharmacology/43.html"><strong aria-hidden="true">3.43.</strong> Anti-Epileptic Drugs</a></li><li class="chapter-item "><a href="../pharmacology/44.html"><strong aria-hidden="true">3.44.</strong> Headaches</a></li><li class="chapter-item "><a href="../pharmacology/45.html"><strong aria-hidden="true">3.45.</strong> Stimulants and Weight Loss</a></li><li class="chapter-item "><a href="../pharmacology/46.html"><strong aria-hidden="true">3.46.</strong> Opioids</a></li><li class="chapter-item "><a href="../pharmacology/47.html"><strong aria-hidden="true">3.47.</strong> Local Anesthetics</a></li><li class="chapter-item "><a href="../pharmacology/48.html"><strong aria-hidden="true">3.48.</strong> General Anesthesia</a></li><li class="chapter-item "><a href="../pharmacology/49.html"><strong aria-hidden="true">3.49.</strong> Drugs of Abuse &amp; Ethanol</a></li><li class="chapter-item "><a href="../pharmacology/50.html"><strong aria-hidden="true">3.50.</strong> Anti-Anxiety / Sleep Pharmacology</a></li><li class="chapter-item "><a href="../pharmacology/51.html"><strong aria-hidden="true">3.51.</strong> Bipolar (Lithium) Pharmacology</a></li><li class="chapter-item "><a href="../pharmacology/52.html"><strong aria-hidden="true">3.52.</strong> Anti-Depressants</a></li><li class="chapter-item "><a href="../pharmacology/53.html"><strong aria-hidden="true">3.53.</strong> Anti-Psychotics</a></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">4.</strong> Psychiatry</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">4.1.</strong> Dopamine Pathways, Antipsychotics, and EPS</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.2.</strong> Eating Disorders</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.3.</strong> Ego Defenses</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.4.</strong> Serotonin Syndrome vs. Neuroleptic Malignant Syndrome</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.5.</strong> Schizophrenia vs. Schizophreniform vs. Schizoaffective vs. Schizoid vs. Schizotypal</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.6.</strong> Bipolar Disorder: criteria, types, symptoms, and treatment</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.7.</strong> Somatoform Disorders (Somatic Symptom, Conversion, Illness Anxiety, Factitious, Malingering)</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.8.</strong> Major Depression and SSRI's/SNRI's</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.9.</strong> Normal Grief vs. Pathologic Grief vs. Major Depression vs. Adjustment Disorder vs. Anxiety</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">5.</strong> Immunology</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">5.1.</strong> Blood Transfusion Reactions</div></li><li class="chapter-item "><div><strong aria-hidden="true">5.2.</strong> Chediak-Higashi vs. Chronic Granulomatous vs. Leukocyte Adhesion vs. Wiskott-Aldrich</div></li><li class="chapter-item "><div><strong aria-hidden="true">5.3.</strong> Autoantibodies Rapid Review</div></li><li class="chapter-item "><div><strong aria-hidden="true">5.4.</strong> Hypersensitivity</div></li><li class="chapter-item "><div><strong aria-hidden="true">5.5.</strong> HLA Subtypes &amp; Associations</div></li><li class="chapter-item "><div><strong aria-hidden="true">5.6.</strong> Transplant Rejection</div></li><li class="chapter-item "><div><strong aria-hidden="true">5.7.</strong> Vaccines</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">6.</strong> Neurology</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">6.1.</strong> Circle of Willis</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.2.</strong> Vertigo (Different Types, Dix-Hallpike Maneuver, Treatment)</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.3.</strong> Brain Tumors</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.4.</strong> Neuromuscular Junction</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.5.</strong> Weber vs. Rinne Test &amp; Conductive vs. Sensorineural Hearing Loss</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.6.</strong> Strokes &amp; The Rule of 4s</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.7.</strong> Upper vs. Lower Motor Neuron Lesions</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.8.</strong> Spinal Cord Pathways</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.9.</strong> Visual Field Defects</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.10.</strong> Neurocutaneous Disorders</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.11.</strong> Sleep (Cycle, EEG)</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.12.</strong> Basal Ganglia (Direct vs. Indirect Pathways)</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">7.</strong> Ethics, Biostats, and Epidemiology</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">7.1.</strong> Core Ethical Principles</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.2.</strong> Capacity vs Competency</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.3.</strong> Informed Consent</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.4.</strong> EMTALA Laws</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.5.</strong> Sensitivity, Specificity, PPV, NPV</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.6.</strong> Case Control vs. Cohort Study</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.7.</strong> Emancipated Minors</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.8.</strong> Consent vs Assent</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.9.</strong> Next of Kin, Living Wills, &amp; Power of Attorney</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.10.</strong> Ethics (USMLE/COMLEX Practice Questions)</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">8.</strong> Microbiology</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">8.1.</strong> Microbiology of Bioterrorism Agents</div></li><li class="chapter-item "><div><strong aria-hidden="true">8.2.</strong> Rabies Guidelines</div></li><li class="chapter-item "><div><strong aria-hidden="true">8.3.</strong> Coronavirus Disease 2019 (COVID-19)</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">9.</strong> Endocrinology</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">9.1.</strong> Adrenal Enzyme Deficiencies</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">10.</strong> Cardiovascular</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">10.1.</strong> Electrocardiograms (ECG)</div></li><li class="chapter-item "><div><strong aria-hidden="true">10.2.</strong> Vasculitis</div></li><li class="chapter-item "><div><strong aria-hidden="true">10.3.</strong> Chest Pain Rapid Review</div></li><li class="chapter-item "><div><strong aria-hidden="true">10.4.</strong> Heart Murmurs | Locations, Maneuvers, Buzzwords</div></li><li class="chapter-item "><div><strong aria-hidden="true">10.5.</strong> AV Blocks (1st, 2nd, and 3rd Degree)</div></li><li class="chapter-item "><div><strong aria-hidden="true">10.6.</strong> Types of Shock (Cardiogenic, Hypovolemic, Septic, Neurogenic, Anaphylactic)</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">11.</strong> Anatomy</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">11.1.</strong> Celiac Trunk Anatomy</div></li><li class="chapter-item "><div><strong aria-hidden="true">11.2.</strong> Lower Extremity Nerve Injuries</div></li><li class="chapter-item "><div><strong aria-hidden="true">11.3.</strong> Cranial Nerve Anatomy</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">12.</strong> MSK &amp; Skin</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">12.1.</strong> Dermatology</div></li><li class="chapter-item "><div><strong aria-hidden="true">12.2.</strong> Lymph Anatomy &amp; Drainage</div></li><li class="chapter-item "><div><strong aria-hidden="true">12.3.</strong> Anatomy on USMLE</div></li><li class="chapter-item "><div><strong aria-hidden="true">12.4.</strong> Upper Extremity Nerve Injuries</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">13.</strong> Renal</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">13.1.</strong> Acute Kidney Injury (AKI)</div></li><li class="chapter-item "><div><strong aria-hidden="true">13.2.</strong> Acid/Base</div></li><li class="chapter-item "><div><strong aria-hidden="true">13.3.</strong> Renal Tubular Acidosis</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">14.</strong> Reproductive &amp; Development</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">14.1.</strong> Polyhydramnios vs. Oligohydramnios</div></li><li class="chapter-item "><div><strong aria-hidden="true">14.2.</strong> Ovarian Pathology &amp; Tumors</div></li><li class="chapter-item "><div><strong aria-hidden="true">14.3.</strong> Epididymitis vs. Torsion vs. Hydrocele vs. Varicocele</div></li><li class="chapter-item "><div><strong aria-hidden="true">14.4.</strong> Ectoderm, Endoderm, &amp; Mesoderm</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">15.</strong> Respiratory</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">15.1.</strong> Obstructive vs. Restrictive Lung Disease</div></li><li class="chapter-item "><div><strong aria-hidden="true">15.2.</strong> Rales vs. Rhonchi</div></li><li class="chapter-item "><div><strong aria-hidden="true">15.3.</strong> CURB-65 Pneumonia Scale</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">16.</strong> Hematology &amp; Oncology</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">16.1.</strong> Anemia (Types, Findings, Lab Values)</div></li><li class="chapter-item "><div><strong aria-hidden="true">16.2.</strong> Bleeding Disorders (ITP vs TTP vs HUS vs DIC)</div></li><li class="chapter-item "><div><strong aria-hidden="true">16.3.</strong> Leukemia</div></li><li class="chapter-item "><div><strong aria-hidden="true">16.4.</strong> Coagulation Cascade</div></li><li class="chapter-item "><div><strong aria-hidden="true">16.5.</strong> Apoptosis (Intrinsic, Extrinsic Pathways) vs. Necrosis</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">17.</strong> Gastrointestinal (GI)</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">17.1.</strong> Crohn's vs. Ulcerative Colitis</div></li><li class="chapter-item "><div><strong aria-hidden="true">17.2.</strong> Cholecystitis vs. Cholelithiasis vs. Cholangitis vs. Choledocholithiasis</div></li><li class="chapter-item "><div><strong aria-hidden="true">17.3.</strong> Bilirubin</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">18.</strong> High Yield Images</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">18.1.</strong> 40 High Yield Images for USMLE (CT, X-Ray, Histology)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.2.</strong> High Yield Images (pt. 2)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.3.</strong> High Yield Images (pt. 3)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.4.</strong> High Yield Images (pt. 4)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.5.</strong> High Yield Images (pt. 5)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.6.</strong> High Yield Images (pt. 6)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.7.</strong> High Yield Images (pt. 7)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.8.</strong> High Yield Images (pt. 8)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.9.</strong> High Yield CT Scans (Part 1)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.10.</strong> High Yield CT Scans (Part 2)</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">19.</strong> Video Question Bank</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">19.1.</strong> Question #1</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.2.</strong> Question #2</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.3.</strong> Question #3</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.4.</strong> Question #4</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.5.</strong> Question #5</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.6.</strong> Question #6</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.7.</strong> Question #7</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.8.</strong> Question #8</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.9.</strong> Question #9</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.10.</strong> Question #10</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.11.</strong> Question #11</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.12.</strong> Question #14</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.13.</strong> Question #15</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.14.</strong> Question #16</div></li></ol></li></ol>
            </div>
            <div id="sidebar-resize-handle" class="sidebar-resize-handle"></div>
        </nav>

        <div id="page-wrapper" class="page-wrapper">

            <div class="page">
                
                <div id="menu-bar-hover-placeholder"></div>
                <div id="menu-bar" class="menu-bar sticky bordered">
                    <div class="left-buttons">
                        <button id="sidebar-toggle" class="icon-button" type="button" title="Toggle Table of Contents" aria-label="Toggle Table of Contents" aria-controls="sidebar">
                            <i class="fa fa-bars"></i>
                        </button>
                        <button id="theme-toggle" class="icon-button" type="button" title="Change theme" aria-label="Change theme" aria-haspopup="true" aria-expanded="false" aria-controls="theme-list">
                            <i class="fa fa-paint-brush"></i>
                        </button>
                        <ul id="theme-list" class="theme-popup" aria-label="Themes" role="menu">
                            <li role="none"><button role="menuitem" class="theme" id="light">Light</button></li>
                            <li role="none"><button role="menuitem" class="theme" id="rust">Rust (default)</button></li>
                            <li role="none"><button role="menuitem" class="theme" id="coal">Coal</button></li>
                            <li role="none"><button role="menuitem" class="theme" id="navy">Navy</button></li>
                            <li role="none"><button role="menuitem" class="theme" id="ayu">Ayu</button></li>
                        </ul>
                        
                        <button id="search-toggle" class="icon-button" type="button" title="Search. (Shortkey: s)" aria-label="Toggle Searchbar" aria-expanded="false" aria-keyshortcuts="S" aria-controls="searchbar">
                            <i class="fa fa-search"></i>
                        </button>
                        
                    </div>

                    <h1 class="menu-title">Medical Summary</h1>

                    <div class="right-buttons">
                        
                        <a href="../print.html" title="Print this book" aria-label="Print this book">
                            <i id="print-button" class="fa fa-print"></i>
                        </a>
                        
                        
                        <a href="https://github.com/easys7/med" title="Git repository" aria-label="Git repository">
                            <i id="git-repository-button" class="fa fa-github"></i>
                        </a>
                        
                    </div>
                </div>

                
                <div id="search-wrapper" class="hidden">
                    <form id="searchbar-outer" class="searchbar-outer">
                        <input type="search" name="search" id="searchbar" name="searchbar" placeholder="Search this book ..." aria-controls="searchresults-outer" aria-describedby="searchresults-header">
                    </form>
                    <div id="searchresults-outer" class="searchresults-outer hidden">
                        <div id="searchresults-header" class="searchresults-header"></div>
                        <ul id="searchresults">
                        </ul>
                    </div>
                </div>
                

                <!-- Apply ARIA attributes after the sidebar and the sidebar toggle button are added to the DOM -->
                <script type="text/javascript">
                    document.getElementById('sidebar-toggle').setAttribute('aria-expanded', sidebar === 'visible');
                    document.getElementById('sidebar').setAttribute('aria-hidden', sidebar !== 'visible');
                    Array.from(document.querySelectorAll('#sidebar a')).forEach(function(link) {
                        link.setAttribute('tabIndex', sidebar === 'visible' ? 0 : -1);
                    });
                </script>

                <div id="content" class="content">
                    <main>
                        <h1 id="anti-neoplastics"><a class="header" href="#anti-neoplastics">Anti-Neoplastics</a></h1>
<ul>
<li><a href="#antineoplastics-big-picture">Antineoplastics Big Picture</a></li>
<li><a href="#nucleotides">Nucleotides</a></li>
<li><a href="#purine-analogues-todo">Purine Analogues (TODO)</a>
<ul>
<li><a href="#6-mercaptopurine-6-mp">6-Mercaptopurine (6-MP)</a></li>
<li><a href="#mycophenolate">Mycophenolate</a></li>
<li><a href="#ribavirin">Ribavirin</a></li>
</ul>
</li>
<li><a href="#folic-acid-antagonists">Folic Acid Antagonists</a>
<ul>
<li><a href="#methotrexate-mtx">Methotrexate (MTX)</a></li>
<li><a href="#leucovorin-folinic-acid">Leucovorin (Folinic Acid)</a></li>
</ul>
</li>
<li><a href="#pyrimidine-analogues">Pyrimidine Analogues</a>
<ul>
<li><a href="#5-flurouracil-5-fu">5-Flurouracil (5-FU)</a></li>
<li><a href="#cytarabine">Cytarabine</a></li>
</ul>
</li>
<li><a href="#nitrogen-mustards">Nitrogen Mustards</a>
<ul>
<li><a href="#cyclophosphamide--lfosfamide">Cyclophosphamide / lfosfamide</a></li>
<li><a href="#melphalan">Melphalan</a></li>
</ul>
</li>
<li><a href="#nitrosoureas">Nitrosoureas</a>
<ul>
<li><a href="#carmustine--lomustine">Carmustine / Lomustine</a></li>
</ul>
</li>
<li><a href="#platinum-agents">Platinum Agents</a>
<ul>
<li><a href="#cisplatin--carboplatin--oxaliplatin">Cisplatin / Carboplatin / Oxaliplatin</a></li>
</ul>
</li>
<li><a href="#other-alkylating-agents">Other Alkylating Agents</a>
<ul>
<li><a href="#busulfan">Busulfan</a></li>
<li><a href="#procarbazinedacarbazine">Procarbazine/Dacarbazine</a></li>
</ul>
</li>
<li><a href="#natural-antibiotics">Natural Antibiotics</a>
<ul>
<li><a href="#actinomycin-d">Actinomycin D</a></li>
<li><a href="#bleomycin">Bleomycin</a></li>
</ul>
</li>
<li><a href="#anthracyclines">Anthracyclines</a>
<ul>
<li><a href="#doxorubicindaunorubicinepirubicin">Doxorubicin/Daunorubicin/Epirubicin</a></li>
</ul>
</li>
<li><a href="#topoisomerase-inhibitors">Topoisomerase Inhibitors</a>
<ul>
<li><a href="#etoposide-topo-ii">Etoposide (TOPO II)</a></li>
<li><a href="#irinotecan-topotecan-topo-1">Irinotecan, Topotecan (TOPO 1)</a></li>
</ul>
</li>
<li><a href="#how-do-cells-dividemove">How do Cells Divide/Move?</a></li>
<li><a href="#vinca-alkaloids--taxanes">Vinca Alkaloids &amp; Taxanes</a>
<ul>
<li><a href="#vinblastinevincristine">Vinblastine/Vincristine</a></li>
<li><a href="#paclitaxeldocetaxel">Paclitaxel/Docetaxel</a></li>
</ul>
</li>
<li><a href="#chemo-regimens-examples">Chemo Regimens Examples</a></li>
<li><a href="#hormonal-big-picture">Hormonal Big Picture</a>
<ul>
<li><a href="#estrogen-dependent-tissue">Estrogen dependent tissue</a></li>
<li><a href="#androgen-dependent-tissue">Androgen dependent tissue</a></li>
<li><a href="#estrogen-modifiersinhibitors">Estrogen Modifiers/Inhibitors</a>
<ul>
<li><a href="#tamoxifen">Tamoxifen</a></li>
<li><a href="#aromatase-inhibitors">Aromatase Inhibitors</a></li>
</ul>
</li>
<li><a href="#androgen-inhibitors">Androgen Inhibitors</a>
<ul>
<li><a href="#gnrh-analogues-leuprolidegoserelin">GnRH Analogues: Leuprolide/Goserelin</a></li>
<li><a href="#flutamide">Flutamide</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="#monoclonal-antibodies">Monoclonal Antibodies</a>
<ul>
<li><a href="#trastuzumab">Trastuzumab</a></li>
<li><a href="#rituximab">Rituximab</a></li>
<li><a href="#cetuximab">Cetuximab</a></li>
<li><a href="#bevacizumab">Bevacizumab</a></li>
<li><a href="#bortezomib">Bortezomib</a></li>
</ul>
</li>
<li><a href="#tyrosine-kinase-inhibitors">Tyrosine Kinase Inhibitors</a>
<ul>
<li><a href="#imatinib">Imatinib</a></li>
<li><a href="#erlotinibgefitinb">Erlotinib/Gefitinb</a></li>
</ul>
</li>
<li><a href="#gene-therapy">Gene Therapy</a>
<ul>
<li><a href="#cart-t-therapy">CART-T therapy</a></li>
</ul>
</li>
<li><a href="#miscellaneous">Miscellaneous</a>
<ul>
<li><a href="#l-asparaginase">L-Asparaginase</a></li>
<li><a href="#hydroxyurea">Hydroxyurea</a></li>
<li><a href="#thalidomide--lenalidomide">Thalidomide &amp; Lenalidomide</a></li>
<li><a href="#vorinostat">Vorinostat</a></li>
</ul>
</li>
</ul>
<h1 id="antineoplastics-big-picture"><a class="header" href="#antineoplastics-big-picture">Antineoplastics Big Picture</a></h1>
<p><strong>Goal: Stop cell growth</strong></p>
<p><strong>How?</strong></p>
<ul>
<li><em>Block Nucleotide synthesis (Building blocks)</em>- <strong>S Phase</strong>
<ul>
<li>Antimetabolites: MTX, 6-MP, 5-FU</li>
</ul>
</li>
<li><em>Block DNA replication</em>
<ul>
<li>Cross link DNA: Alkylating agents (i.e. Nitrogen mustards, nitrosoureas, Platinum agents, Busulfan)</li>
<li>Intercalates in DNA: Antibiotics</li>
<li>DNA strand break: Bleomycin, Anthracyclines</li>
<li>Block DNA unwinding: Topoisomerase inhibitors</li>
</ul>
</li>
<li><em>Block Cellular division</em>- <strong>M Phase</strong>
<ul>
<li>Vinca alkaloids and Taxanes</li>
</ul>
</li>
<li><em>Block Growth Signals</em>
<ul>
<li>Estrogen and Androgen modifiers</li>
<li>Monoclonal antibodies</li>
<li>Tyrosine Kinase inhibitors</li>
</ul>
</li>
<li><em>Other Mechanisms</em>
<ul>
<li>L-Asparaginase and Thalidomide</li>
</ul>
</li>
</ul>
<p><strong>Antineoplastics Schematic</strong></p>
<p><img src="https://i1.wp.com/nursekey.com/wp-content/uploads/2017/05/F00045Xf45-03-9780323087896.jpg?w=960" alt="Antineoplastics Schematic" /></p>
<h1 id="nucleotides"><a class="header" href="#nucleotides">Nucleotides</a></h1>
<p>Nucleoside: Base + Sugar</p>
<p>Nucleotide: Base + Sugar + Phosphate</p>
<p>Drugs that block Base synthesis- All work during Synthesis (S) Phase</p>
<ul>
<li>Block Purines (Adenine, Guanine)
<ul>
<li>6-Mercaptopurine, 6-Thioguanine</li>
<li>Mycophenolate, Ribavirin</li>
</ul>
</li>
<li>Block Pyrimidines (Cytosine, Uracil, Thymine)
<ul>
<li>Leflunomide</li>
<li>Methotrexate</li>
<li>5-Fluorouracil, Cytarabine</li>
<li>Hydroxyurea</li>
</ul>
</li>
</ul>
<h1 id="purine-analogues-todo"><a class="header" href="#purine-analogues-todo">Purine Analogues (TODO)</a></h1>
<h2 id="6-mercaptopurine-6-mp"><a class="header" href="#6-mercaptopurine-6-mp">6-Mercaptopurine (6-MP)</a></h2>
<h2 id="mycophenolate"><a class="header" href="#mycophenolate">Mycophenolate</a></h2>
<h2 id="ribavirin"><a class="header" href="#ribavirin">Ribavirin</a></h2>
<h1 id="folic-acid-antagonists"><a class="header" href="#folic-acid-antagonists">Folic Acid Antagonists</a></h1>
<h2 id="methotrexate-mtx"><a class="header" href="#methotrexate-mtx">Methotrexate (MTX)</a></h2>
<p><em>MOA:</em> Inhibit <strong>Dihydrofolate reductase</strong> inhibiting Tetrahydrofolate
synthesis thus inhibiting thymidine synthesis</p>
<p><em>Use:</em></p>
<ul>
<li>Neoplastic use: Leukemias, lymphomas</li>
<li>Non-Neoplastic: RA, Psoriasis, Ectopic pregnancy, Inflammatory Bowel Disease</li>
</ul>
<p><em>SE:</em></p>
<ul>
<li><em><strong>Myelosuppression (WBC, RBC, Platelet)</strong></em></li>
<li>Oral ulcers</li>
<li><em><strong>Pulmonary Fibrosis</strong></em></li>
<li>Hepatotoxicity</li>
</ul>
<h2 id="leucovorin-folinic-acid"><a class="header" href="#leucovorin-folinic-acid">Leucovorin (Folinic Acid)</a></h2>
<p><em>MOA:</em> Form of tetrahydrofolate bypasses dihydrofolate reductase</p>
<p><em>Use:</em> Reverse myelosuppression caused by MTX</p>
<h1 id="pyrimidine-analogues"><a class="header" href="#pyrimidine-analogues">Pyrimidine Analogues</a></h1>
<h2 id="5-flurouracil-5-fu"><a class="header" href="#5-flurouracil-5-fu">5-Flurouracil (5-FU)</a></h2>
<p><em>MOA:</em> Pyrimidine analogue which complexes with and <strong>inhibits
Thymidylate Synthase</strong> inhibiting Thymidine Synthesis</p>
<p><em>Use:</em></p>
<ul>
<li>Solid growing tumors: Colon cancer, pancreatic cancer</li>
<li><strong>Effects enhanced by addition of leucovorin</strong>
<ul>
<li>Leucovorin stabilizes 5-FU binding to Thymidylate synthase</li>
</ul>
</li>
</ul>
<p><em>SE:</em> Myelosuppression</p>
<h2 id="cytarabine"><a class="header" href="#cytarabine">Cytarabine</a></h2>
<p><em>MOA:</em> Pyrimidine analogue incorporates into DNA and inhibits DNA polymerase</p>
<p><em>Use:</em> Acute Myelogenous Leukemia</p>
<p><em>SE:</em> Myelosuppression</p>
<h1 id="nitrogen-mustards"><a class="header" href="#nitrogen-mustards">Nitrogen Mustards</a></h1>
<h2 id="cyclophosphamide--lfosfamide"><a class="header" href="#cyclophosphamide--lfosfamide">Cyclophosphamide / lfosfamide</a></h2>
<p><em>MOA:</em> Cross link DNA inhibiting DNA replications</p>
<p><em>Use:</em></p>
<ul>
<li>Solid tumors</li>
<li>Non-Hodgkin's Lymphoma</li>
<li>Autoimmune disease: SLE, RA</li>
</ul>
<p><em>SE:</em></p>
<ul>
<li>Myelosuppression</li>
<li><strong>Hemorrhagic cystitis caused by acrolein in the preparation</strong>*
<ul>
<li>Prevented by hydration and MESNA- thiol group in MESNA</li>
</ul>
</li>
</ul>
<h2 id="melphalan"><a class="header" href="#melphalan">Melphalan</a></h2>
<ul>
<li>Used for Multiple Myeloma</li>
</ul>
<h1 id="nitrosoureas"><a class="header" href="#nitrosoureas">Nitrosoureas</a></h1>
<h2 id="carmustine--lomustine"><a class="header" href="#carmustine--lomustine">Carmustine / Lomustine</a></h2>
<p><em>MOA:</em> Cross link DNA and <strong>Cross the blood brain barrier</strong></p>
<p><em>Use:</em> Brain tumors</p>
<p><em>SE:</em></p>
<ul>
<li>CNS toxicity (Seizure)</li>
<li>Myelosuppression</li>
</ul>
<h1 id="platinum-agents"><a class="header" href="#platinum-agents">Platinum Agents</a></h1>
<h2 id="cisplatin--carboplatin--oxaliplatin"><a class="header" href="#cisplatin--carboplatin--oxaliplatin">Cisplatin / Carboplatin / Oxaliplatin</a></h2>
<p><em>MOA:</em> Cross link DNA
<em>Use:</em></p>
<ul>
<li>Testicular and Ovarian Cancer
<em>SE:</em> All related to free radicals</li>
<li><strong>Nephrotoxicity</strong>, Hypomagnesemia and hypokalemia
<ul>
<li>Prevent with amifostine (free radical scavenger) and hydration</li>
</ul>
</li>
<li>Peripheral neuropathy</li>
<li>Ototoxicity</li>
</ul>
<p>Carboplatin is least toxic</p>
<h1 id="other-alkylating-agents"><a class="header" href="#other-alkylating-agents">Other Alkylating Agents</a></h1>
<h2 id="busulfan"><a class="header" href="#busulfan">Busulfan</a></h2>
<p><em>MOA:</em> Cross links DNA</p>
<p><em>Use:</em> CML</p>
<p><em>SE:</em></p>
<ul>
<li><em><strong>Severe Myelosuppression</strong></em>
<ul>
<li>Sometimes used to ablate patient bone marrow before bone marrow transplant</li>
</ul>
</li>
<li><strong>Pulmonary Fibrosis</strong></li>
</ul>
<h2 id="procarbazinedacarbazine"><a class="header" href="#procarbazinedacarbazine">Procarbazine/Dacarbazine</a></h2>
<p><em>MOA:</em> Not fully understood- Possibly break DNA strands</p>
<p><em>Use:</em> Lymphomas, others</p>
<p><em>SE:</em></p>
<ul>
<li><strong>Inhibits Alcohol formaldehyde causing Disulfiram reaction</strong>
<ul>
<li>Avoid ETOH Use</li>
</ul>
</li>
<li><strong>Inhibits Monoamine Oxidase enzyme (MAO) causing Hypertensive Crisis with
foods containing Tyramine (Aged cheese and wine)</strong>
<ul>
<li>Tyramine displaces NE from synaptic cleft- NE is normally broken down by MAO</li>
<li>Extra unbroken NE causes HTN</li>
</ul>
</li>
</ul>
<h1 id="natural-antibiotics"><a class="header" href="#natural-antibiotics">Natural Antibiotics</a></h1>
<h2 id="actinomycin-d"><a class="header" href="#actinomycin-d">Actinomycin D</a></h2>
<p><em>MOA:</em> Intercalates in DNA</p>
<p><em>Use:</em> <strong>Childhood tumors- Mostly primitive tumors</strong></p>
<ul>
<li>Wilms Tumor (Nephroblastoma- Tumor of the adrenal medulla)</li>
<li>Ewing Sarcoma (Primitive tumor of the bone)</li>
<li>Rhabomyosarcoma</li>
</ul>
<p><em>SE:</em> Myelosuppression</p>
<h2 id="bleomycin"><a class="header" href="#bleomycin">Bleomycin</a></h2>
<p><em>MOA:</em> Induces free radical formation causing DNA breaks- <strong>Inhibits DNA Ligase during G2 Phase</strong></p>
<p><em>Use:</em> Testicular cancer</p>
<p><em>SE:</em> Pulmonary Fibrosis</p>
<p><em>What Other Antineoplastic causes Pulmonary Fibrosis?</em></p>
<ul>
<li>Bleomycin, MTX, Busulfan</li>
</ul>
<h1 id="anthracyclines"><a class="header" href="#anthracyclines">Anthracyclines</a></h1>
<h2 id="doxorubicindaunorubicinepirubicin"><a class="header" href="#doxorubicindaunorubicinepirubicin">Doxorubicin/Daunorubicin/Epirubicin</a></h2>
<p><strong>Suffix- Bicin</strong></p>
<p><em>MOA:</em> Generates free radicals causing DNA breaks using free iron</p>
<p><em>Use:</em> Breast cancer, lymphomas, leukemias</p>
<p><em>SE:</em></p>
<ul>
<li><strong>Dilated Cardiomyopathy related to iron deposits in the heart from the drug</strong>
<ul>
<li>Need MUGA scan to evaluate heart function before starting</li>
<li><strong>Dexrazoxane</strong> is an iron chelating agent used to prevent cardiotoxicity</li>
<li><strong>Epirubicin is least cardiotoxic</strong></li>
</ul>
</li>
<li>Severe alopecia</li>
</ul>
<h1 id="topoisomerase-inhibitors"><a class="header" href="#topoisomerase-inhibitors">Topoisomerase Inhibitors</a></h1>
<h2 id="etoposide-topo-ii"><a class="header" href="#etoposide-topo-ii">Etoposide (TOPO II)</a></h2>
<p><em>MOA:</em> Inhibits <em>Topoisomerase II</em> inhibiting DNA unwinding and replication</p>
<p><em>Use:</em> Solid tumors (Testicular tumors and lung)</p>
<p><em>SE:</em> Myelosuppression, Alopecia</p>
<h2 id="irinotecan-topotecan-topo-1"><a class="header" href="#irinotecan-topotecan-topo-1">Irinotecan, Topotecan (TOPO 1)</a></h2>
<p><em>MOA:</em> Inhibits <em>Topoisomerase I</em></p>
<p><em>Use:</em> Colon, Ovarian and lung</p>
<p><em>SE:</em></p>
<ul>
<li>Severe myelosuppression</li>
<li><strong>Severe Diarrhea</strong> (Due to suppression of Gl cells which have high turnover rates)</li>
</ul>
<h1 id="how-do-cells-dividemove"><a class="header" href="#how-do-cells-dividemove">How do Cells Divide/Move?</a></h1>
<ul>
<li>Cells use microtubules which are composed of helix of polymerized heterodimers (Alpha and Beta tubulin)</li>
<li>Microtubules are incorporated into flagella, cilia mitotic spindles X</li>
<li>Involved in
<ul>
<li>Mitosis (Anticancer: Vinca and Taxanes)</li>
<li>White blood cell extravasation (Anti Gout - Colchicine)</li>
<li>Sperm/Cilia movement</li>
<li>Axoplasmic transport</li>
<li>Fungus and worms moving <em>(Antifungal: Griseofulvin and Anthelmintic: Mebendazole)</em></li>
</ul>
</li>
</ul>
<h1 id="vinca-alkaloids--taxanes"><a class="header" href="#vinca-alkaloids--taxanes">Vinca Alkaloids &amp; Taxanes</a></h1>
<h2 id="vinblastinevincristine"><a class="header" href="#vinblastinevincristine">Vinblastine/Vincristine</a></h2>
<p><em>MOA:</em> Bind B-Tubulin and <strong>inhibits its polymerization into microtubules</strong>
preventing mitotic spindle formation- cell can't divide</p>
<ul>
<li>Works specifically in M-Phase</li>
</ul>
<p><em>Use:</em>
Vincristine: Hodgkin's Lymphoma
Vinblastine: Metastatic testicular tumors</p>
<p><em>SE:</em></p>
<ul>
<li>VinBlastine: <strong>Bone marrow suppression</strong></li>
<li>Vincristine: <strong>Peripheral neuropathy (Areflexia, peripheral neuritis, constipation)</strong></li>
</ul>
<h2 id="paclitaxeldocetaxel"><a class="header" href="#paclitaxeldocetaxel">Paclitaxel/Docetaxel</a></h2>
<p><em>MOA:</em> <strong>Hyper Stabilize</strong> polymerized microtubules in M Phase
-&gt; mitotic spindles can’t break down
-&gt; cell can't divide</p>
<p><em>Use:</em> Ovarian and breast</p>
<p>*SE</p>
<ul>
<li>Hypersensitivity</li>
<li>Myelosuppression, neuropathy</li>
</ul>
<h1 id="chemo-regimens-examples"><a class="header" href="#chemo-regimens-examples">Chemo Regimens Examples</a></h1>
<ul>
<li><strong>Wilms Tumor</strong>: Actinomycin D, Vincristine, Cyclophosphamide</li>
<li><strong>Colon Cancer</strong>: 5-FU, Adriamycin (Doxorubicin), Mitomycin</li>
<li><strong>Cervical Carcinoma</strong>: Vincristine</li>
<li><strong>Pancreatic Cancer</strong>: Gemcitabine</li>
</ul>
<h1 id="hormonal-big-picture"><a class="header" href="#hormonal-big-picture">Hormonal Big Picture</a></h1>
<h2 id="estrogen-dependent-tissue"><a class="header" href="#estrogen-dependent-tissue"><strong>Estrogen</strong> dependent tissue</a></h2>
<ul>
<li><strong>Breast</strong> (Breast Cancer)
<ul>
<li>Breast cancer status
<ul>
<li>Estrogen(ER) +ve/-ve, Progesterone (PR) +ve/-ve, Her2/Neu +ve/-ve</li>
<li>ER +ve breast CA treatment
<ul>
<li>Block Estrogen- Tamoxifen</li>
<li>Block Androgen conversion to Estrogen- Aromatase Inhibitors</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li><strong>Endometrium</strong> (Endometrial Cancer)</li>
<li><strong>Bone</strong> (Deficiency leads to osteoporosis)</li>
</ul>
<h2 id="androgen-dependent-tissue"><a class="header" href="#androgen-dependent-tissue"><strong>Androgen</strong> dependent tissue</a></h2>
<ul>
<li><strong>Prostate</strong> (Benign Prostatic Hyperplasia, Prostate Cancer)</li>
<li>Prostate CA Treatment
<ul>
<li>Block Gonadotropin/Androgen axis- Leuprolide/Goserelin</li>
<li>Block Testosterone conversion to DHT- Flutamide</li>
</ul>
</li>
</ul>
<h2 id="estrogen-modifiersinhibitors"><a class="header" href="#estrogen-modifiersinhibitors">Estrogen Modifiers/Inhibitors</a></h2>
<h3 id="tamoxifen"><a class="header" href="#tamoxifen">Tamoxifen</a></h3>
<p><em>MOA:</em> Selective estrogen receptor modulator(SERM)</p>
<ul>
<li><strong>Antagonist in breast</strong></li>
<li><strong>Agonist in Bone &amp; Endometrium</strong></li>
</ul>
<p><em>Use:</em> ER +ve breast cancer</p>
<p><em>SE:</em></p>
<ul>
<li><strong>Endometrial carcinoma (Agonist in Endometrium)</strong></li>
<li><strong>Thromboembolic events</strong> (i.e. DVT/PE) because Estrogen increases clotting factors synthesis by liver</li>
<li>Hot flashes</li>
</ul>
<h3 id="aromatase-inhibitors"><a class="header" href="#aromatase-inhibitors">Aromatase Inhibitors</a></h3>
<p><strong>Anastrozole/Letrozole/Exemestane</strong>
<em>MOA:</em> Inhibit Aromatase enzyme responsible for peripheral conversion of androgens to estrogen</p>
<p><em>Use:</em> ER+ve breast cancer in postmenopausal women</p>
<p><strong>Source of estrogen</strong></p>
<ul>
<li>Pre-menopausal: Ovaries</li>
<li>Postmenopausal: Peripheral conversion</li>
</ul>
<h2 id="androgen-inhibitors"><a class="header" href="#androgen-inhibitors">Androgen Inhibitors</a></h2>
<h3 id="gnrh-analogues-leuprolidegoserelin"><a class="header" href="#gnrh-analogues-leuprolidegoserelin">GnRH Analogues: Leuprolide/Goserelin</a></h3>
<p><em>MOA:</em> GnRH analogues</p>
<ul>
<li>When used in <strong>pulsatile</strong> fashion: <strong>Agonists</strong></li>
<li>When used <strong>continuously: Antagonists</strong> because it downregulates GnRH receptors in pituitary leading to decreased FSH/LH)</li>
</ul>
<p><em>Use:</em></p>
<ul>
<li>Prostate Adenocarcinoma (Decrease LH— Decrease Androgens)</li>
<li>Other indications</li>
</ul>
<p><em>SE:</em></p>
<ul>
<li>Transient disease flare in initial treatment because of agonist property- treated with flutamide</li>
</ul>
<h3 id="flutamide"><a class="header" href="#flutamide">Flutamide</a></h3>
<p><em>MOA:</em> Nonsteroidal competitive inhibitor at the Dihydrotestosterone (DHT) receptor</p>
<p><em>Use:</em> Prostate Adenocarcinoma</p>
<h1 id="monoclonal-antibodies"><a class="header" href="#monoclonal-antibodies">Monoclonal Antibodies</a></h1>
<h2 id="trastuzumab"><a class="header" href="#trastuzumab">Trastuzumab</a></h2>
<p><em>MOA:</em> Blocks <strong>Her2/Neu Tyrosine Kinase Receptor</strong></p>
<p><em>Use:</em> Her2/Neu +ve Breast Cancer</p>
<p><em>SE:</em> Cardiotoxicity</p>
<h2 id="rituximab"><a class="header" href="#rituximab">Rituximab</a></h2>
<p><em>MOA:</em> Blocks <strong>CD20</strong> found on most B-Cell neoplasm</p>
<p><em>Use:</em> Non-Hodgkin's Lymphoma, Chronic Myeloid Leukemia</p>
<p><em>SE:</em> Infusion related reactions</p>
<h2 id="cetuximab"><a class="header" href="#cetuximab">Cetuximab</a></h2>
<p><em>MOA:</em> Blocks <strong>EGFR</strong></p>
<p><em>Use:</em> Stage IV Colon Cancer</p>
<h2 id="bevacizumab"><a class="header" href="#bevacizumab">Bevacizumab</a></h2>
<p><em>MOA:</em> Blocks <strong>VEGF</strong> Inhibiting angiogenesis</p>
<p><em>Use:</em> Solid tumors, proliferative diabetic retinopathy, macular degeneration</p>
<p><em>SE:</em> Impaired wound healing</p>
<h2 id="bortezomib"><a class="header" href="#bortezomib">Bortezomib</a></h2>
<p><strong>Proteasome Inhibitor inducing apoptosis at G2-M Phase</strong>
(Proteasomes degrade damaged ubiquitin tagged proteins)</p>
<p>Use: <strong>Multiple Myeloma</strong></p>
<h1 id="tyrosine-kinase-inhibitors"><a class="header" href="#tyrosine-kinase-inhibitors">Tyrosine Kinase Inhibitors</a></h1>
<h2 id="imatinib"><a class="header" href="#imatinib">Imatinib</a></h2>
<p><em>MOA:</em> Tyrosine kinase inhibitor</p>
<p><em>Use:</em></p>
<ul>
<li>Specific for BCR-ABL tyrosine kinase (Philadelphia chromosome) in Chronic Myeloid Leukemia</li>
<li>C-Kit tyrosine kinase in Gl stromal tumors (mesenchymal origin)</li>
</ul>
<p><em>SE:</em> Fluid Retention</p>
<h2 id="erlotinibgefitinb"><a class="header" href="#erlotinibgefitinb">Erlotinib/Gefitinb</a></h2>
<p><em>MOA:</em> Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor</p>
<p><em>Use:</em> <strong>Non-Small Cell lung cancer</strong></p>
<h1 id="gene-therapy"><a class="header" href="#gene-therapy">Gene Therapy</a></h1>
<h2 id="cart-t-therapy"><a class="header" href="#cart-t-therapy">CART-T therapy</a></h2>
<p><strong>CTLO19 (Tisagenlecleucel)</strong></p>
<p><em>MOA:</em> T cells isolated from patients, genetically altered to recognize the B-cell marker CD19.</p>
<p><em>Use:</em> ALL and B-cell lymphomas</p>
<p><em>SE:</em> Cytokine release syndrome (flu-like symptoms to life threatening respiratory distress)</p>
<h1 id="miscellaneous"><a class="header" href="#miscellaneous">Miscellaneous</a></h1>
<h2 id="l-asparaginase"><a class="header" href="#l-asparaginase">L-Asparaginase</a></h2>
<p><em>MOA:</em></p>
<ul>
<li>Enzyme produced by Escherichia coli</li>
<li>I-Asparagine is a nonessential amino acid
<ul>
<li>Most cells can synthesize except certain <strong>lymphoid malignancies</strong></li>
</ul>
</li>
<li><strong>L-asparaginase depletes I-Asparagine</strong> in Tumor cells w/ low or no levels asparagine synthetase</li>
</ul>
<p><em>Use:</em> ALL</p>
<p><em>SE:</em> Hypersensitivity and resistance</p>
<h2 id="hydroxyurea"><a class="header" href="#hydroxyurea">Hydroxyurea</a></h2>
<p><em>MOA:</em> Inhibits ribonucleotide reductase</p>
<p><em>Uses:</em></p>
<ul>
<li>Historically - CML</li>
<li>Currently - <strong>Sickle cell anemia</strong>
<ul>
<li><strong>Increase Fetal Hbg</strong></li>
</ul>
</li>
</ul>
<p><em>SE:</em> Myelosuppression</p>
<h2 id="thalidomide--lenalidomide"><a class="header" href="#thalidomide--lenalidomide">Thalidomide &amp; Lenalidomide</a></h2>
<p><em>MOA:</em></p>
<ul>
<li><strong>Unknown</strong></li>
<li>Stimulates T and natural killer cells, inhibits
angiogenesis and modulates hematopoietic stem cell differentiation</li>
</ul>
<p><em>Use:</em></p>
<ul>
<li><strong>Multiple myeloma</strong></li>
<li>Lenalidomide - myelodysplastic syndrome</li>
</ul>
<p><em>SE:</em></p>
<ul>
<li>Thalidomide: <strong>sedation &amp; peripheral neuropathy</strong></li>
<li>Lenalidomide (Less toxicity) <strong>leukopenia</strong>, hepatotoxicity and renal dysfunction.</li>
</ul>
<h2 id="vorinostat"><a class="header" href="#vorinostat">Vorinostat</a></h2>
<p><em>MOA:</em></p>
<ul>
<li>Histone deacetylase inhibitor</li>
<li>Acetylated histones relax chromatin structure which allows more <strong>transcription -&gt; cell cycle arrest</strong></li>
</ul>
<p><em>Uses:</em> Cutaneous T cell lymphomas</p>
<p><em>SE:</em> DVT/PE, thrombocytopenia, and anemia.</p>

                    </main>

                    <nav class="nav-wrapper" aria-label="Page navigation">
                        <!-- Mobile navigation buttons -->
                        
                            <a rel="prev" href="../pharmacology/12.html" class="mobile-nav-chapters previous" title="Previous chapter" aria-label="Previous chapter" aria-keyshortcuts="Left">
                                <i class="fa fa-angle-left"></i>
                            </a>
                        

                        
                            <a rel="next" href="../pharmacology/14.html" class="mobile-nav-chapters next" title="Next chapter" aria-label="Next chapter" aria-keyshortcuts="Right">
                                <i class="fa fa-angle-right"></i>
                            </a>
                        

                        <div style="clear: both"></div>
                    </nav>
                </div>
            </div>

            <nav class="nav-wide-wrapper" aria-label="Page navigation">
                
                    <a rel="prev" href="../pharmacology/12.html" class="nav-chapters previous" title="Previous chapter" aria-label="Previous chapter" aria-keyshortcuts="Left">
                        <i class="fa fa-angle-left"></i>
                    </a>
                

                
                    <a rel="next" href="../pharmacology/14.html" class="nav-chapters next" title="Next chapter" aria-label="Next chapter" aria-keyshortcuts="Right">
                        <i class="fa fa-angle-right"></i>
                    </a>
                
            </nav>

        </div>

        

        

        

        
        <script type="text/javascript">
            window.playground_copyable = true;
        </script>
        

        

        
        <script src="../elasticlunr.min.js" type="text/javascript" charset="utf-8"></script>
        <script src="../mark.min.js" type="text/javascript" charset="utf-8"></script>
        <script src="../searcher.js" type="text/javascript" charset="utf-8"></script>
        

        <script src="../clipboard.min.js" type="text/javascript" charset="utf-8"></script>
        <script src="../highlight.js" type="text/javascript" charset="utf-8"></script>
        <script src="../book.js" type="text/javascript" charset="utf-8"></script>

        <!-- Custom JS scripts -->
        

        

    </body>
</html>
